2
Orphan Designations
0
FDA Approvals
2
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| myelofibrosis | an orally active, small molecule inhibitor of bromodomain (BRD) and extra terminal domain (BET) family proteins | Orphan Designation | - |
| plasma cell myeloma | small molecule inhibitor of E1A binding protein (EP300) and cyclic-AMP response element-binding protein (CBP) bromodomain (BRD) | Orphan Designation | - |